Quantcast
Channel: DNA
Viewing all 463 articles
Browse latest View live

'Dark DNA' could change how we think about evolution

$
0
0

dna sequencing

DNA sequencing technology is helping scientists unravel questions that humans have been asking about animals for centuries.

By mapping out animal genomes, we now have a better idea of how the giraffe got its huge neck and why snakes are so long. Genome sequencing allows us to compare and contrast the DNA of different animals and work out how they evolved in their own unique ways.

But in some cases we're faced with a mystery. Some animal genomes seem to be missing certain genes, ones that appear in other similar species and must be present to keep the animals alive. These apparently missing genes have been dubbed "dark DNA". And its existence could change the way we think about evolution.

My colleagues and I first encountered this phenomenon when sequencing the genome of the sand rat (Psammomys obesus), a species of gerbil that lives in deserts. In particular we wanted to study the gerbil's genes related to the production of insulin, to understand why this animal is particularly susceptible to type 2 diabetes.

But when we looked for a gene called Pdx1 that controls the secretion of insulin, we found it was missing, as were 87 other genes surrounding it. Some of these missing genes, including Pdx1, are essential and without them an animal cannot survive. So where are they?

The first clue was that, in several of the sand rat's body tissues, we found the chemical products that the instructions from the "missing" genes would create. This would only be possible if the genes were present somewhere in the genome, indicating that they weren't really missing but just hidden.

The DNA sequences of these genes are very rich in G and C molecules, two of the four "base" molecules that make up DNA. We know GC-rich sequences cause problems for certain DNA-sequencing technologies. This makes it more likely that the genes we were looking for were hard to detect rather than missing. For this reason, we call the hidden sequence "dark DNA" as a reference to dark matter, the stuff that we think makes up about 25% of the universe but that we can't actually detect.

Gerbil

By studying the sand rat genome further, we found that one part of it in particular had many more mutations than are found in other rodent genomes. All the genes within this mutation hotspot now have very GC-rich DNA, and have mutated to such a degree that they are hard to detect using standard methods. Excessive mutation will often stop a gene from working, yet somehow the sand rat's genes manage to still fulfil their roles despite radical change to the DNA sequence.

This is a very difficult task for genes. It's like winning Countdown using only vowels.

This kind of dark DNA has previously been found in birds. Scientists have found that 274 genes are "missing" from currently sequenced bird genomes. These include the gene for leptin (a hormone that regulates energy balance), which scientists have been unable to find for many years. Once again, these genes have a very high GC content and their products are found in the birds' body tissues, even though the genes appear to be missing from the genome sequences.

Shedding light on dark DNA

Most textbook definitions of evolution state that it occurs in two stages: mutation followed by natural selection. DNA mutation is a common and continuous process, and occurs completely at random.

Natural selection then acts to determine whether mutations are kept and passed on or not, usually depending on whether they result in higher reproductive success. In short, mutation creates the variation in an organism's DNA, natural selection decides whether it stays or if it goes, and so biases the direction of evolution.

DNA genes

But hotspots of high mutation within a genome mean genes in certain locations have a higher chance of mutating than others.

This means that such hotspots could be an underappreciated mechanism that could also bias the direction of evolution, meaning natural selection may not be the sole driving force.

So far, dark DNA seems to be present in two very diverse and distinct types of animal. But it's still not clear how widespread it could be.

Could all animal genomes contain dark DNA and, if not, what makes gerbils and birds so unique? The most exciting puzzle to solve will be working out what effect dark DNA has had on animal evolution.

In the example of the sand rat, the mutation hotspot may have made the animal's adaptation to desert life possible. But on the other hand, the mutation may have occurred so quickly that natural selection hasn't been able to act fast enough to remove anything detrimental in the DNA. If true, this would mean that the detrimental mutations could prevent the sand rat from surviving outside its current desert environment.

The discovery of such a weird phenomenon certainly raises questions about how genomes evolve, and what could have been missed from existing genome sequencing projects. Perhaps we need to go back and take a closer look.

SEE ALSO: A DNA-testing startup just launched an 'app store' for genetics

Join the conversation about this story »

NOW WATCH: All the nasty things inside a pimple — and why you should stop popping them


A Chicagoland hospital is adding a new test to its annual checkup — and it could be the future of medicine

$
0
0

Hulick with patient   010

A Chicagoland hospital system has added something new to its patients' annual checkups: the option to get a genetic test.

Until now, DNA tests have tended to live either in the consumer realm or through referrals to specialists when a patient brings it up.

NorthShore University HealthSystem wants to bring that conversation about genetics into every doctor's office during annual checkups.

The plan is to be "more proactive" in how the health system deals with health, rather than reactive, Dr. Peter Hulick, director of the Center for Personalized Medicine at NorthShore, told Business Insider.

That's going to be increasingly important as hospitals start to take on more responsibility, by getting paid to make sure patients are healthy rather than looking solely at the number of people they treat, Hulick said.

How it works

  • A few days before you're scheduled to go in for your annual physical, NorthShore will send out a questionnaire that asks about your family history and if you're interested in getting a genetic test.
  • Your answers get put into the hospital's electronic health records, and an algorithm helps determine what tests a person might be a good candidate to take, if any. They could be tests that screen for a hereditary-cancer risk (like the BRCA1 and 2 genes associated with breast and ovarian cancer), cardiovascular risk, or tests that show how you might respond to certain medication.
  • Patients are responsible for paying for the test, which can be covered by insurance. 
  • Whether a person gets a test — say, a hereditary-cancer screening — is based on national guidelines, Hulick said, and people will get only the tests they might need. Dr. Robert Nussbaum, the chief medical officer at Invitae, a company that provides genetics tests to NorthShore, said doing a hereditary-cancer test if someone doesn't have a family history of the disease is "inappropriate for a general screening" and could cause unnecessary anxiety.

MolecularDiag_UnknownMachineNameDr. John Mark Revis, a primary-care physician at NorthShore, told Business Insider that ahead of the program starting, primary-care doctors were briefed about the tests they'd be prescribing and what the tests might tell them about their patients' health.

Because patients won't be getting tested for everything they could possibly have, Revis said he anticipated this becoming something NorthShore does every year, rather than once in a patient's life. That's because family histories might change or the science might make a test more relevant.

Genetic testing goes mainstream

Erica Ramos, a genetic counselor at Illumina and incoming president of the National Society of Genetic Counselors, told Business Insider that doing genetic testing at the primary-care level was a newer approach that reflected "where we're headed."

Other companies have taken on ambitious genetic-sequencing projects. Geisinger Health System, which operates out of Pennsylvania, has sequenced the DNA of 92,815 patients, with 3.5% of them getting a result that showed they had a disease-causing genetic variant.

For now, one of the concerns is there isn't much information about whether taking these genetics tests improves people's health. Would they be just as healthy and live just as long if they never had these tests?

One study, recently published in the Annals of Internal Medicine, concluded that when primary-care practices used whole-genome sequencing (that is, reading the entire genetic code of a person), they were able to come up with some findings for their patients, but it was still unclear how helpful those findings were.

Getting to the bottom of whether these tests could add value is something NorthShore and Invitae said they were interested in.

In the meantime, Hulick said he's gotten positive feedback from the program. Even patients who didn't need a genetics test said they felt satisfied in having the option.

For more science news, useful insights, and cool stuff, follow us on Instagram.

SEE ALSO: I tried National Geographic's next-generation ancestry test

DON'T MISS: I've taken AncestryDNA, 23andMe, and National Geographic genetics tests — here's how to choose which one to try

Join the conversation about this story »

NOW WATCH: NASA's most accurate map of where Americans can witness the rare total solar eclipse this year

I took a DNA test that claims to reveal the best wine for you — here's the verdict

$
0
0

IMG_0447.JPG

I've taken DNA tests that have told me all about my ancestry and health and even one that told me which superhero genes I had.

When I heard about Vinome, a test that uses your DNA and taste preferences to pair you up with wines you might like, I had to give it a shot.

Within our genome, there are genes that correspond to certain taste and smell preferences. For example, some people are genetically predisposed to hate the taste of cilantro while others love it. Based on those genes and a survey about what foods you like and dislike, Vinome uses its algorithm to find wines from the wineries it partners with that you might enjoy.

Going into the test, I was skeptical about what it could tell me. I knew of only one or two genes related to taste, and I figured that wasn't enough to tell me whether I liked merlot or pinot noir. Plus, my go-to wine has always been pinot grigio, and I figured a test wouldn't make me automatically change my mind about it in favor of another wine.

With that in mind, I started the process, and here's what I learned.

SEE ALSO: I tried National Geographic's next-generation ancestry test and was surprised by my results

DON'T MISS: I shipped my spit to AncestryDNA to see how much I could learn from my genes — and found out my family history is more complex than I thought

Vinome's genetics test is a part of the recently launched Helix marketplace. In March, I took National Geographic's ancestry test, which is part of the Helix marketplace. That meant this time, Vinome and Helix didn't need to ship me another kit to collect my spit sample; they could just use the data from the sample I'd submitted when I learned about my ancestry.

Source: Business Insider



Instead, I went straight to Helix's website to put in my order for Vinome. After scrolling down, I clicked on the "Wine Explorer" test.



Going into the test, I was skeptical that DNA could play that big a role in my taste in wine. I scrolled to the science section of the test's description. It informed me that my taste is mostly influenced by factors other than genetics. "Results are for your entertainment and do not determine or limit your ability to taste or enjoy wines," it read.



See the rest of the story at Business Insider

23andMe gets $200 million in funding to bring its genetic testing to the masses

$
0
0

Anne Wojcicki

23andMe, the DNA testing company that turns saliva into in-depth genetic analysis, is raising $200 million in funding led by Sequoia Capital, sources close to the situation confirmed to Business Insider. 

This puts the company at a pre-money valuation of $1.5 billion, according to Axios. 

The funding round — first reported by TechCrunch — is the company's first since 2015, when 23andMe raised $115 million at a reported $1.1 billion valuation. 

23andMe was co-founded in 2006 by CEO Anne Wojcicki (the sister of YouTube boss Susan Wojcicki) and Linda Avey, who left the company in 2009. It's since developed a reputation for its $199 direct-to-consumer health reports, though not without some hurdles.

In 2013, the US Food and Drug Administration (FDA) barred the company from sending any data related to health to customers, over concerns that the company misrepresented genetic tests as medical advice. This prevented the company from providing information about things like a customer's risk for developing a certain type of cancer, which was one of its major products. 

The company started selling the tests again in 2015 with the FDA's approval, and in April 2017, the FDA officially authorized 23andMe to market its direct-to-consumer tests for 10 different medical diseases and conditions, including Parkinson's and Alzheimer's. 

23andMe declined to comment. 

SEE ALSO: Slack is making its way out of the office — and into the kitchen and onto the farm

Join the conversation about this story »

NOW WATCH: This machine lets you charge your device wherever you are in the room

A company that wants to be the 'global standard network of genomic data' raised $240 million

$
0
0

Genetic sequencing DNA samples

Wuxi NextCODE, a genomic information company, has raised $240 million in one of the biggest rounds ever raised by a genomics company.

The series B round, led by Sequoia Capital, added another $165 million to the $75 million the company raised in May. In total, the company has raised $255 million.

The field of genomics is getting more crowded, with companies tackling everything from building the hardware that sequence samples of DNA, to companies that are building tests to tell you all about your health or ancestry, to information technology companies like NextCODE. NextCODE works both with pharmaceutical companies to help them compile and store genomic data and by selling genomic tests to users in China.

The company's CEO, Hannes Smarason, compared the way NextCODE operates for other people in the life sciences industry to how the Bloomberg terminal functions for the financial services industry. When it comes to consumer tests, Smarason said the aim is to be a network like Facebook. In the end, the aim is to be the "global standard network of genomic data." 

The funding round will be used to build up the company's platform, help it better use artificial intelligence in its services, and build out its commercial team, Smarason said. The money might also be used to acquire some companies that can help the company better digitize, manage, or analyze genomic data. 

SEE ALSO: Investors including Google Ventures poured $93 million into a company that's building personalized cancer vaccines

DON'T MISS: A biotech CEO who sold his last company for $14 billion explains what it takes to build a company

Join the conversation about this story »

NOW WATCH: Terrifying NASA footage from space shows the giant Hurricane Harvey about to slam the Texas coast

Scientists may be able to discover new drugs by 'challenging' organisms with clusters of random chemistry

$
0
0

FILE PHOTO:  A DNA double helix is seen in an undated artist's illustration released by the National Human Genome Research Institute to Reuters on May 15, 2012.   REUTERS/National Human Genome Research Institute/Handout/File Photo

I was cutting my grass when the battery in my iPod died.

Instead of enjoying the distraction of music, my brain switched to its usual nerd mode of thinking about molecules. Within a few passes of cut grass, I was pondering the biggest “Why not?” of my scientific career: Could we discover new drugs and useful agricultural compounds by challenging organisms with clusters of random chemistry?

My background is in molecular biology – the study of DNA, genes and how an organism’s blueprints are decoded and assembled into life. The discipline requires an understanding of how molecular codes are deciphered and turned into functional biology. Anyone in this field is plagued with dreams of dancing molecules, interacting and performing the roles that turn DNA information into our food, the plants in our environment and our families.

Every day in the lab we move genes around. It’s easy. Not meant to generate new products for consumers, moving DNA is used as a research tool that lets us understand how specific genes work. A classic example is the NPR1 gene from the model plant Arabidopsis; it’s a defense gene that confers enhanced tolerance to disease when you drop it into almost any plant’s genome. Manipulating genetic information – in plants, microbes and some animals – is commonplace.

On that half-cut lawn it occurred to me – instead of inserting DNA information we understand, what if we introduced a scrambled mess of random DNA code into a plant or bacterium? Could we identify random bits of genetic information that could give rise to small proteins (called peptides) that change an organism’s physiology or development?

Normally DNA encodes instructions that coordinate the order of the amino acid building blocks in a protein. Each amino acid has specific chemical characteristics. Strung together in a peptide chain, they fold into a protein that provides cellular structure or function, based on the complementary chemistries of its amino acid components.

My hypothesis was that a short, scrambled DNA message could give rise to a novel string of amino acids. This would be a small cluster of discrete chemistry that likely never existed before on the planet. The vast majority of the time it would be meaningless and just become cellular rubbish. But maybe on rare occasion it could do something new and desirable.

To test the hypothesis, our research team used randomized templates to synthesize trillions of random DNA fragments using simple DNA amplification techniques. Each was flanked by the genetic instructions to start and stop production of a peptide inside the plant.

Then we used standard genetic engineering techniques to insert a novel DNA sequence into thousands of individual Arabidopsis thaliana plants – and sat back to watch what would happen when the plants turned the random genetic information into little random peptides. We were hoping for cases where specific protein structures might find a connection with biological chemistry and we’d see the result in the plants themselves.

As the plants grew, we were blown away by what we observed.

Some plants were flowering early. Others were small and stunted. Others grew larger leaves. Some were loaded with healthy purple pigments. Still others grew up to a point…then died.

We then retrieved the particular random DNA sequence we’d added to each, a simple feat for a molecular biologist, and inserted the same sequence into new plants. Most of the time the random information affected the new generation of plants in exactly the same way, demonstrating that something was indeed happening related to the added, garbled information. We recently published our results in the journal Plant Physiology.

What is this random information doing inside the cell? The small random molecules generated from the inserted DNA instructions could affect a specific process, just by chance. They could bind a needed nutrient. They might inhibit a key enzyme. They could turn on flowering or protect a plant from freezing. Nobody really knows exactly how until the plants are examined in detail one by one. These new proteins may also be good models to design new useful molecules with similar chemical properties, but that are more durable in the cell. Our goal is to produce a compound that may be applied to crops to change the way plants grow and behave, or perhaps stop the growth of invasive or weedy plants.

The process is like throwing monkey wrenches into a complicated machine. Most of the time they clank around and affect nothing; but once in a long while a wrench catches in some critical gears and brings the machine to a halt. Other times the wrench might short-circuit a wasteful process, allowing the machine to run more efficiently. These peptides are molecular monkey wrenches.

Some of these peptides must interfere with an important biological process because they kill the plant. These findings bring to light new vulnerabilities in plants that researchers could exploit to develop environmentally friendly and nontoxic herbicides. Agriculture currently relies on a few relatively old chemistries, cultivation (using fossil fuels) or human labor to control the weeds that compete with food plants for resources. Good weed control means that valuable fertilizers, water and sunlight go only to the desired plants, rather than weeds. So new herbicide chemistries would be extremely valuable as farmers work to produce food for growing populations.

But why stop at plants? We are using the same approach to discover the next generation of antibiotics. The goal is to identify random information that affects a single species of problematic bacterium. For instance, we could potentially target S. aureus, the antibiotic-resistant bacteria that causes MRSA. We are hunting for new molecules that could destroy MRSA-related bacteria while leaving the rest of the microbiome unaffected. These experiments are underway in our lab.

Randomness may pinpoint undiscovered vulnerabilities or opportunities in plants, bacteria and other organisms. There even may be applications in solving human disease. The future is exciting as we mine the vast collections of new molecules and study how they integrate with biology to produce important desired outcomes.

Several of the molecules we’ve already identified slow plant growth. Future products from this technology might even be applied to make lawns grow more slowly. While others may find this advance helpful, I’ll have to skip using it. Cutting the grass gets my good ideas flowing.

Join the conversation about this story »

NOW WATCH: Here are all the major changes coming to your iPhone September 19

Animated map shows how cats spread across the world

$
0
0

You can find house cats on every continent except Antarctica. But that wasn't always the case. How did cats make it across oceans and into households worldwide? 

The secret lies in ancient cat DNA. Here's how cats spread across the world. 

It started around 10,000 years ago in what's now modern-day Turkey. DNA analysis shows this is where cats' wild ancestors likely originated. Wild cats proved to be effective rodent control for early farmers. 

As the agricultural revolution spread, cats joined for the ride.By 2,500 BC years ago cats had reached Cyprus where no cats had existed before. Over the next few thousand years they accompanied humans north into Bulgaria and Romania.

By 800 BC, cats had found their calling in Egypt. Cats weren't just an object of worship here. Egyptian cats, specifically, became popular among the Romans and Vikings who brought cats on their ships for pest control. 

These two groups took the feline revolution by storm. 

Helping cats spread across all of Africa, Europe, and Asia. By the time Europeans were sailing to the Americas cats were common shipmates.

 Today, one-third of American homes have at least one cat. That's about 93.5 million house cats in the US, alone. 

Now that they've conquered the world at humans' side, cats can rest easy.

Follow Tech Insider: On Facebook

Join the conversation about this story »

Scientists have discovered a potentially suicidal problem with going to Mars

$
0
0

first humans mars astronaut glove shutterstock_341700152

  • Cosmic rays are a powerful type of radiation that pose a risk to astronauts.
  • Beyond Earth's protective magnetic shield, they increase the risk of cancer and other health effects.
  • The first Mars explorers may face a two-fold higher risk than previously thought, according to a recent study in mice.
  • However, researchers may soon develop better radiation shielding.

NASA is dead-set on sending astronauts to Mars within the next 15 to 20 years. China has said it hopes to send people there between 2020 and 2030, and even Russia is floating plans to put boots on the red planet.

Meanwhile, SpaceX founder Elon Musk is trying to cut the cost of spaceflight enough to start establishing a permanent Martian colony of 1 million people as soon as possible.

But if a study of radiation exposure in mice has any bearing on humans, going to Mars may be much more dangerous than anyone expected.

The root problem is cosmic rays, as detailed in a May 2017 Nature study and highlighted by a recent Business Insider video.

The danger of cosmic rays

Cosmic rays are high-energy atomic and subatomic particles that get blasted out from exploding stars, black holes, and other powerful sources in space. The rays can damage DNA, increase the risk of cancer, lead to vision-impairing cataracts, cause nervous system damage, and give rise to blood circulation issues, among other health effects in astronauts.

Researchers know that astronauts receive much higher radiation exposure than those of us who remain on Earth, since the planet's atmosphere absorbs a lot of that harmful energy.

cosmic raysEarth's magnetic field also diverts and deflects a lot of space radiation, which helps protect astronauts on the International Space Station — which orbits just 250 miles above the planet.

On a trip to Mars, however, it's open season for cosmic rays. In addition, the planet lost its magnetic field billions of years ago, which will expose the first Mars explorers to extra radiation. 

Health scientist Frank Cucinotta and his colleague Eliedonna Cacao at the University of Nevada Las Vegas researched this problem by reexamining the results of four previous studies of tumors in mice.

In addition of looking for the effects of a cosmic ray's direct hit to cells, which could coax them to develop into cancer, the researchers also looked at how secondary or "non-targeted effects" might play a role.

What they found is a risk of cancer in deep space (at least for mice) that's about two times higher than previous estimates.

Why deep-space travel may be more dangerous than expected

The researchers think this elevated cancer risk comes down to how damaged DNA spreads throughout the body.

When a cell is struck by a cosmic ray, it doesn't simply keep the change to itself. It can give off chemical signals to other cells, which might trigger nearby healthy cells to also mutate into cancer.

Previous models hadn't really accounted for this domino effect. Even more worrisome, the type of radiation responsible for causing the effect was "only modestly decreased by radiation shielding," Cucinotta and Cacao wrote in their study.

Human exploration of Mars need not stop before it starts, though.

astrorad mars radiation shield suit reuters RTS119FE

Space agencies and private companies are actively working to mitigate space radiation. An Israeli startup is developing a body vest designed to more fully absorb radiation, for example, and one NASA scientist recently pitched the idea of deploying a satellite that'd serve as an artificial magnetic shield to divert harmful radiation around Mars.

And as the researchers noted in their study, "significant differences" exist between mouse-model cancer rates and those actually seen in people. "These differences could limit the applicability of the predictions described in this paper," they wrote.

But the scientists add that this knowledge gap is precisely why future deep-space explorers and their respective agencies should exercise caution.

"[S]tudies ... are urgently needed prior to long-term space missions outside the protection of the Earth’s geomagnetic sphere," they said.

SEE ALSO: 12 amazing facts you probably didn't know about Mars

DON'T MISS: Elon Musk has published an outline of his ambitious plan to colonize Mars with 1 million people

Join the conversation about this story »

NOW WATCH: Scientists overlooked a major problem with going to Mars — and they fear it could be a suicide mission


Scientists discovered people who are highly-intelligent have 52 genes in common

$
0
0

If you aced your SATs, you can thank at least a few of your genes. Scientist analyzed the DNA of 78,308 people. They discovered a link between intelligence and 52 specific genes.

The better individuals did in broad intelligence tests, the more frequently these genes appeared. But researchers aren't sure what the correlations mean because they don't know exactly what each gene does

Four of them control cell development. Three others control activities inside neurons.

But it isn't clear how the others could make you smart. Scientists want to experiment with brain cells to find out.

One method would take cells from people of differing intelligence and have those cells create neuron clusters.

By studying the way the neuron clusters interact, they could determine how their genetics affect neuron development.

But researchers stress genetics alone won't make you Einstein. The genes only accounted for 5% variation in intelligence scores.

Environmental factors also play a big role. So don't think you can skip school, just because your parents are rocket scientists.

Join the conversation about this story »

NASA sent one identical twin brother to space for a year and studied how it changed him — here are the latest results

$
0
0

NASA astronauts Scott and Mark Kelly

When NASA astronaut Scott Kelly stood up last March after spending a year in space, he was two inches taller.

Kelly is part of a study NASA is conducting to assess how the human body changes as a result of space travel, using Scott Kelly and his twin brother Mark Kelly as subjects. While Scott spent 340 days aboard the International Space Station, Mark stayed on Earth, giving NASA the rare opportunity to compare two identical sets of DNA— one that has been exposed to the stressors of space, and one that has not.

Temporary additions in height are just one of many alterations the researchers have documented so far. Scott and Mark have the same genes, but Scott's year in space appears to have strongly affected the way those genes are expressed.

"We can observe the entire human biological system responding to space flight," Christopher Mason, a principal investigator on the NASA Twins study and an associate professor at Weill Cornell Medical College, told Business Insider.

Researchers already knew that taking our bodies for a jaunt outside Earth's protective atmosphere has plenty of effects on the human body, like stretching your spine, shrinking your muscles, and messing up your sleep cycle— but the effects of long-term exposure to space have been less well-known.

NASA astronaut Scott KellyThe results of the twin study, though preliminary, are already giving scientists a ton to think about.

Mason said they've seen "thousands and thousands of genes change how they are turned on and turned off," almost immediately once an astronaut reaches space. Some of these changes stick around for days or even weeks after astronauts return to Earth.

The new findings about gene expression build on some preliminary results that NASA released in February. Researchers hope to use the full set of data, which could take some time to comb through completely, to better prepare for future deep-space missions.

Here are some of the most interesting results so far:

  • Scott's telomeres got longer, then shrunk back to normal. Scott's telomeres, or the caps at the end of chromosomes, became longer than his brother's while he was in space, but quickly returned to their normal length once he returned home."That is exactly the opposite of what we thought,” Susan Bailey, a radiation biologist at Colorado State University in Fort Collins, told Nature in Februrary. That's because shorter telomeres are generally associated with getting older. Scientists are still studying what this means, but it could be linked to more exercise and eating fewer calories while in space, according to NASA.
  • Scott's genetic expression changed in a bunch of ways. Scott's genes showed both increased and decreased levels of methylation, a process that results in genes getting turned on and off. “Some of the most exciting things that we’ve seen from looking at gene expression in space is that we really see an explosion, like fireworks taking off, as soon as the human body gets into space,” Mason said in a recent statement. According to NASA, this could "indicate genes that are more sensitive to a changing environment whether on Earth or in space."
  • The twins hosted different gut bacteria. Researchers noted differences between Scott's and Mark's gut bacteria (essentially the microbes that aid in digestion) throughout the year-long study. This was probably a result of their different diets and environments, NASA said.
  • Scientists are looking for what they're calling a "space gene." By sequencing the RNA in the twins' white blood cells, researchers found more than 200,000 RNA molecules that were expressed differently between the brothers. It is normal for twins to have unique mutations in their genome, but scientists are "looking closer to see if a 'space gene' could have been activated while Scott was in space," NASA said.

SEE ALSO: I got my dog’s DNA tested and what I learned shocked me

DON'T MISS: 8 weird things that happen to your body if you live in space for a year

Join the conversation about this story »

NOW WATCH: NASA and Lockheed Martin reveal their plans to build the first-ever Mars space station

There's new evidence of how our DNA shapes depression and other disorders like it

$
0
0

sad woman depressed lonely girl

  • Scientists are uncovering promising links between specific parts of our DNA and a range of disorders such as anxiety, depression, and obsessive-compulsive disorder.
  • As with any disease, having certain genes or mutations in those genes doesn't mean you'll go on to develop the disorders, but it may play a key role.
  • The research also helps highlight the biological underpinnings of mental illness, something that could help with the development of better treatments.

 

When you fall and break a bone, an X-ray shows the crack. There's no equivalent diagnostic for disorders of the brain — a shortfall that's made it difficult for millions of people with conditions ranging from anxiety to obsessive-compulsive disorder to get treatment.

A spate of new research may change that. In a handful of recent studies, scientists have identified what they believe to be some of the most reliable genetic hallmarks of mental illness, a discovery that would transform our current approach to treating the disorders. If we can better understand the genes that influence psychiatric diseases, we can design treatments that accurately target the part of the brain that they appear to effect.

"Beyond giving us so much data to explore, being able to show that depression is a brain disease, that there is biology associated with it, I think that's really critical,"Roy Perlis, the director of the Center for Experimental Drugs and Diagnostics at Massachusetts General Hospital, told Business Insider in 2016. "These are brain diseases, like any other. They're not someone's fault."

LifeProfile DNA Kit 2The latest research suggests that our DNA may play an outsize role in psychiatric disease. As far as diseases go, mental illnesses are among those that are the most likely to be passed down from parent to child, a finding only recently illuminated by decades of research. 

"Genetics plays a very big role in your risk of getting these diseases," Elinor Karlsson, a geneticist at the Broad Institute of MIT and Harvard University, told Business Insider. 

Still, looking at someone's genome alone will probably never be enough to determine if they'll go on to develop a psychiatric disease — other factors, including environmental factors like severe stress, play a strong role too. But scientists are discovering more and more clues that suggest that the key to discovering new treatments for mental illnesses will center on a deeper dive into our DNA.

"We need to go after this genetic component," Karlsson said.

In the summer of 2016, Perlis used data from 23andMe to pinpoint 17 genetic variants linked with major depressive disorder. But Perlis and 23andMe aren't the only ones making progress in this arena. Earlier this month, researchers at the University of Massachusetts and the Broad Institute identified four genes linked to obsessive-compulsive disorder (OCD), a chronic condition characterized by uncontrollable repetitive thoughts and behaviors. 

'People who have OCD are more likely to have these changes in these genes'

Hyun Ji Noh, a geneticist at the Broad Institute, has read lots of studies showing a link between OCD and genetics. Despite all this promising research, none of the existing papers came to any definitive conclusions about which genes seemed to be tied to the disorder.

So for her latest study, published earlier this month in the journal Nature Communications, she decided to try a different tack.

Instead of just focusing on human DNA, which in the other studies had yielded limited results, she looked at multiple sets of genes — and not just from humans. 

"There are a lot of naturally occurring dog diseases — especially psychiatric diseases — that are very similar to human diseases,"Hyun Ji Noh, a geneticist at the Broad Institute and the lead author on the study, told Business Insider. "So to me it was sort of natural to put dog studies in the context of human disease."

alone sad depressed seaNoh's paper looked at hundreds of genes that had been implicated in psychiatric disease in dogs, mice, and people.

In humans, the researchers found 608 genes. To find out which of these 608 genes was actually tied to OCD, Noh compared what they looked like in hundreds of people with and without the disorder. By the end of the analysis, just four genes emerged that showed up repeatedly in mutated form in people with OCD. 

In these four genes, "a lot of mutations kept showing up for OCD patients but not in the healthy individuals," Noh said.

In other words, these four genes likely play a key role in the biology of the disorder. Still, having a mutation in one of these four genes doesn't necessarily mean you'll go on to develop OCD.

"We know people who have OCD are more likely to have these changes in these genes. But this is one of potentially 100 things that will determine if you have OCD," said Karlsson, who also worked on the paper. "It's complicated," she said.

Chasing 'depression genes'

Like OCD, researchers say depression is influenced heavily by our DNA. But unlike OCD, it's fairly common, occurring in an estimated 16.1 million Americans. Current treatments for depression haven't changed much since the 1950s, and they don't work for everyone.

So, in an effort to find out more about what exactly causes the illness, researchers published a paper in the summer of 2016 in the journal Nature Genetics in which they pinpointed 17 genetic variations, or tweaks in particular genes, that appear to be tied to major depressive disorder, the most debilitating form of the disease that's currently the leading cause of disability worldwide.

The researchers got their data from personal genomics company 23andMe. 

Using data from more than 75,600 people who told the company that they'd been clinically diagnosed with depression and more than 231,700 people who reported no history of depression, Perlis and his team were able to identify 17 areas on DNA that appear to be linked with depression. They also found some ties between these areas and those which have been previously identified as possibly playing a role in other psychiatric disorders, such as schizophrenia.

Scientists have been looking for such genetic hallmarks of depression for years. And while some, like a 2013 study in the journal The Lancet and a 2015 paper in the journal Nature, have yielded promising clues, none have been able to spot any precise, reliable genetic markers of the disease.

At least not until now.

"My group has been chasing depression genes for more than a decade without success, so as you can imagine, we were really thrilled with the outcome," Perlis said.

The hope is that identifying these watermarks in our DNA — tiny areas on genes where high amounts of variation tend to occur among individuals — will help us better understand how genetics and behavior interact to influence disorders like depression.

Still, Perlis said, "this is really just the beginning. Now the hard work is understanding what these findings tell us about how we might better treat [these disorders]."

SEE ALSO: Scientists came to a fascinating conclusion after looking at the DNA of thousands of people with depression

Join the conversation about this story »

NOW WATCH: What fruits and vegetables looked like before we domesticated them

I tested my dog's DNA and learned she's not even close to the breed I thought

$
0
0

izzie 2

Getting your own DNA tested is so last year.

Now you can get a peek inside the genetic makeup of your dog. The method gives a rough estimate (it's not a perfect science), but it offers some intriguing insight for people who may have no idea what breed their best friend comes from.

The purpose of a dog DNA test is "to identify the breed or breed composite, which can be quite helpful information," Urs Giger, a veterinary clinician and researcher at the University of Pennsylvania's School of Veterinary Medicine, told Discover.

In other words, you can learn a lot with a dog DNA test — but like any other DNA test, there are some limits to the accuracy of the results.

I gave it a shot with my family dog, a mixed-breed rescue pooch named Izzie who we adopted from a Golden Retriever shelter in Los Angeles when I was a kid. Here's what I learned.

DON'T MISS: There's new evidence of how our DNA shapes depression and other disorders like it

SEE ALSO: I tried the popular Silicon Valley diet credited with boosting energy and prolonging life — and I can see why people are obsessed

This is Izzie. When I adopted her over a decade ago, I was told she was a mixed-breed golden retriever.

She was only a year old at the time, so no one knew how big she'd get (most goldens reach their full size, about 60 lbs., around age 2) or how she'd behave. Our veterinarian told us she was likely a (smallish) golden retriever mutt.



But Izzie stayed roughly the same size, and we stayed curious about her heritage. Now 15 years old, she's friendly and loyal.

Most people get dog DNA tests so they can find out what kind of behavioral traits to expect — golden retrievers tend to be loyal and good with kids, for example, while dalmatians are super active and generally make good guard dogs.

Source: American Kennel Club



When I got the chance to test her DNA, I seized it. There were several options, but I picked the Wisdom Panel DNA test developed by MARS Veterinary, the world's largest pet healthcare provider.

The "3.0" version of the kit — which you can no longer buy from Mars' website but is still available on Amazon — cost me $79.99 . The newest version, which you can get on their site, is $84.99. 



See the rest of the story at Business Insider

It's possible for one person to have two different sets of DNA — here's how it happens

$
0
0

BI Graphic DNA strand

  • People that have two different sets of DNA are called human chimeras.
  • It can happen when a woman is pregnant with fraternal twins and one embryo dies very early on. The other embryo can "absorb" its twin's cells. 
  • It can also happen after a bone marrow transplant, and (in a smaller scale) during normal pregnancy.

 

In Greek mythology, a chimera was a fire-breathing creature with physical traits of a lion, goat, and dragon. In human beings, a chimera is a person who has two totally different sets of DNA inside their body. It's a bit less dramatic than a fire-breathing monster, sure, but it's still pretty wild.

Even wilder: Human chimeras aren't the result of futuristic genetic tinkering. They can occur naturally, and some people don't even know that they've doubled up on DNA. 

Here's a quick guide to the ways a person can become a human chimera.

It can happen after a bone marrow transplant. 

Testing tubes full of blood are seen at the American Red Cross Charles Drew Donation Center in Washington February 16, 2016.   REUTERS/Gary Cameron

Bone marrow is the tissue inside our bones that's responsible for making white blood cells, red blood cells, and platelets. In bone marrow transplants, doctor uses chemotherapy or radiation to destroy all the recipient's diseased bone marrow, then a donor's healthy marrow is put in its place. 

The donor's bone marrow will keep on making blood cells that have the donor's DNA, according to a Scientific American report. That's how the recipient becomes a chimera. 

In "complete chimerism," 100% of the recipient's blood cells have the donor's DNA, a paper in the journal Nature explained. But the blood can also contain a mix of DNA from both the donor and the recipient — that's called "mixed chimerism." 

This type of chimera has inspired one some interesting storylines in pop culture, Motherboard reports. The 2015 film "Bad Blood" is all about a cancer-patient-turned-serial-killer using the DNA in his blood to implicate his bone marrow donor. 

It can happen when fraternal twins are in utero. 

ultrasound

Scientific American explains that, when a mother is carrying fraternal twins, one of the embryos might die very early in the pregnancy. Then, the other embryo can absorb some cells from the deceased one. The resulting baby ends up with two sets of DNA.

Sometimes these chimeras make the news.

In 2015, a man from Washington took a cheek swab paternity test that said he was technically his son's uncle, not his father. Further testing revealed that the man had different DNA in his saliva and his sperm. Genetic experts believed he was a human chimera, and he had absorbed some of his DNA from a fraternal twin's embryo, BuzzFeed reported. 

A woman named Karen Keegan wound up in a similar situation. Tests said she wasn't the biological mother of her children, but it turned out that the DNA in her blood was different than the DNA in her ovaries. Doctors said her extra DNA most likely came from a fraternal twin — and in 2002 her story became a report in the New England Journal of Medicine.

Since twin loss occurs in an estimated 21 to 30% of multiple-fetus pregnancies, it's possible that many people are chimeras, but may never find out. One genetic expert told BuzzFeed that deliberately testing for chimerism is very difficult, and that there's no real need to do those tests in healthy people.

It can happen during a normal pregnancy. 

baby holding mom's hand

In the 1990s, scientists discovered that a pregnant woman may retain some DNA from her baby, if some fetal cells happen to migrate outside the uterus. The New York Times dubbed it a "pregnancy souvenir" — but it's more scientifically known as "microchimerism."

One way simple way to prove this idea is to test mothers of boys and see if they have any cells with Y chromosomes, which are only present in males. 

In one study, researchers sampled tissue from 26 women who had died during pregnancy or just after giving birth to a boy. In every single sample, they found low concentrations of cells with Y chromosomes, according to the New York Times.

Another study looked at the brains of mothers who had boys. They found traces of male DNA in 63% of the women — even in a woman who was 94 years old, Scientific American reported. This suggests that microchimerism might last a long time post-pregnancy. 

One microchimerism expert told The New York Times that scientists believe it's "very common, if not universal" among pregnant women. Just add it to the list of fascinating things that happen to a woman's body during pregnancy.

Join the conversation about this story »

NOW WATCH: These adorable twin babies are becoming an Instagram sensation

Over a 40-year career, this 'stubborn scientist' helped change the way we think about cancer and genetics

$
0
0

Mary Claire King

  • Mary-Claire King, a geneticist and professor at the University of Washington, was instrumental in the discovery that changed the way we think about cancer. 
  • Her work with the BRCA1 gene that's associated with breast and ovarian cancer came after decades of research during her more than 40-year career. 
  • In the past few years, the impact of her work has started to be felt by the world as cancer genetic testing becomes more widespread. 

 

You might not know the name Mary-Claire King, but you probably know the result of this scientist's most famous work: the BRCA1 gene that's been critical in fighting breast and ovarian cancer.

A geneticist at the University of Washington, King has spent her 40-year career working to better understand human genetics, especially the codes that make up all of us. Her discoveries helped open entire areas of medicine. But it wasn't until the past few years that the effects of her work started to be widely recognized publicly, sparked in part by actor Angelina Jolie's revelation that she had the "faulty" BRCA1 gene, increasing her risk of cancer. 

In 2014, King received a prestigious Lasker award for her work in breast cancer genetics as well as human rights, and in 2016 President Barack Obama acknowledged her work with the the National Medal of Science. 

"At a time when most scientists believed that cancer was caused by viruses, she relentlessly pursued her hunch that certain cancers were linked to inherited genetic mutations," Obama said at the ceremony. "This self-described 'stubborn' scientist kept going until she proved herself right."

King's initial work in genetics for her doctoral thesis in 1975 was the discovery that humans and chimpanzees are 99% genetically similar. Later, she analyzed DNA from grandmothers to help reconnect them with their grandchildren who had been kidnapped as part of Argentina's"dirty war." She was also active during the Civil Rights Movement.

"As a scientist, one is a citizen of the world. And as a citizen of the world, you have certain responsibilities" King said of her activism in an interview with the World Science Festival. 

Arguably, King's biggest impact resulted from her work pinpointing BRCA1, a gene that's critical in producing proteins that repair damaged DNA. 

What we know now, based in part on King's research, is that mutations in the BRCA gene have big implications for a person's cancer risk. The risk of getting breast cancer goes from 7% to an average of 55-65% when you have the BRCA1 or 2 gene mutation, while for ovarian cancer the risk increases from 1% to 30%. Knowing you have one of these genetic tweaks, then, could help doctors make more proactive decisions to treat.

Discovering the genetics of cancer 

Back when King started her work in the 1970s, the link between cancer and genetics hadn't been made. The running theory at the time was that cancer was viral. 

"I thought genetics, evolutionary biology and statistics might add something to the newly launched War on Cancer. And my closest childhood friend had died of cancer. I wanted to try," she told The New York Times in 2015.

Getting a chance to start that research wasn't easy either. On the week leading up to King getting a grant for her research back in April 1981, her husband left her, her house was burgled, and she had a chance encounter with baseball legend Joe DiMaggio. 

Here's her re-telling of the week leading up to her presentation at the National Institutes of Health, which led to the grant.

Finally, after years of figuring out just how genetics and family histories of cancer played a role in cancer risk, in 1990, King found the gene linked to breast cancer and named it BRCA1. After that, there was a race to see who could clone the gene, a move which helped researchers better understand how mutations in the gene led to cancer. 

Now, doctors are able to give tests to their patients who might have a family history of cancer, to see if they might be at an increased risk based on BRCA and other mutations that have since been linked to various forms of cancer. 

A lasting impact

Color CEO Othman Laraki told Business Insider that King is someone who has a "North Pole," which helps her look at data with clear logic. Color sells hereditary cancer — including BRCA1 and 2 and high cholesterol tests — and works with King, who serves as a collaborator and adviser to the company. Working with her, Laraki said, made sense because of her history in working to establish the connection between cancer and genetics, but also to bring that connection to people.

"She’s one of the people who bridge scientific discovery and the knowledge that enables entire populations," Laraki said. 

And that's starting to get even more widespread, especially after a 2013 Supreme Court decision ended the ability to have a patent on the BRCA gene, along with Jolie's diagnosis that spread the word about the gene.

"Mary-Claire King, she's invented something that's almost as relevant a datapoint as your blood pressure," said Feyi Olopade Ayodele, CEO of CancerIQ, a company that builds software to help doctors better understand and access hereditary cancer genetics tests at the preventative level. " That's how impactful genetic testing will be in the future."

SEE ALSO: A cancer treatment that's part of 'a big new field of medicine' just got approved

Join the conversation about this story »

I sent my spit to AncestryDNA and found out that my family history is more complex than I thought

$
0
0

hello

I have to admit: I've become a genetics geek. Ever since I sent my first saliva sample to be analyzed by consumer-genetics company 23andMe, I've become obsessed with what I can find out from a sample of my DNA.

After trying out 23andMe's $199 test, I wanted to see how one of its competitors' tests stacked up.

For $99, AncestryDNA will sequence your genes to help trace your geographic roots. It doesn't provide health and wellness information, although Ancestry launched a program aimed at tracking family-health history called AncestryHealth. The company also recently teamed up with Alphabet's biotechnology company, Calico, to study the genetics of the human lifespan. 

Here's what it was like to use AncestryDNA:

RELATED: I tried 23andMe's new genetics test — and now I know why the company caused such a stir

SEE ALSO: The 7 best science-backed fitness apps

Shortly after I ordered it online, my AncestryDNA kit arrived in the mail in a small box the size of a hardcover book.

Learn more here.



Opening it up, I found a collection tube (and a bag to seal it in once I was done), a set of instructions, and a smaller box to send it all back in.



No stranger to collection tubes, I wasn't quite looking forward to spitting up to the top of the line on this tube. As I learned previously, generating enough spit for the collection process (which helps ensure the company has enough DNA to run it a second time in case of errors) can be hard work.



See the rest of the story at Business Insider

DNA test frees wrongfully convicted man serving time over a 1978 double murder

$
0
0
  • A DNA test led to the freeing of a California man wrongfully convicted for a double murder in 1978.
  • Investigators now say he may have been framed.

california pardon double murder 1978LOS ANGELES (Reuters) - A man wrongfully convicted in California of the 1978 double-murder of a woman and her child is spending his first Thanksgiving Day as a free man in 39 years, after being released on the basis of DNA evidence.

California Governor Jerry Brown pardoned 70-year-old Craig Coley on Wednesday and prison officials quickly set him free, according to prosecutors and police in Simi Valley, where the double-slaying occurred.

Local authorities in Simi Valley, a community just outside Los Angeles, supported the governor's decision.

"The grace with which Mr. Coley has endured his lengthy and unjust incarceration is extraordinary," Brown wrote in the two-page document ordering Coley's release. "I grant this pardon because Mr. Coley did not commit these crimes."

More than 350 people have been exonerated by DNA testing in the United States since 1989, according to New York-based The Innocence Project, which helps people who were wrongfully convicted. On average, convicts who were freed had served 14 years in prison when exonerated.

Coley was convicted in the 1978 murder of his ex-girlfriend, Rhonda Wicht, and her 4-year-old son, Donald, at the apartment where the mother and child lived.

Wicht was beaten and strangled and the boy was smothered to death, Simi Valley police said in a statement on Monday. Coley, who had recently broken up with Wicht, was arrested the day the bodies were discovered.

Coley, who had no criminal history, may have been framed, Brown wrote in the pardon.

In 1980, Coley was convicted and sentenced to life in prison without parole.

He always maintained his innocence, and the governor said that, in prison, Coley turned to religion and avoided gangs. After he appealed to Brown for clemency, the governor ordered a review in 2015.

Biological samples once thought to be lost or destroyed were discovered at a private laboratory, Simi Valley police said, and investigators analyzed a key piece of evidence.

It showed Coley's DNA was not present on the sample. Instead, it bore traces of other people's DNA.

The statement from Simi Valley police did not describe the object, saying only that technology for testing the item was not available when Coley was convicted.

"Reviewing the case in light of the new evidence, we no longer have confidence in the weight of the evidence used to convict Mr. Coley," Simi Valley police and Ventura County prosecutors said in a joint statement earlier this week.

They called the case tragic and pledged to continue reviewing it to determine if they can establish who killed the mother and child 39 years ago.

 

SEE ALSO: Putting crime scene DNA analysis on trial

Join the conversation about this story »

NOW WATCH: How couples improved their sex lives in just one week

I've taken AncestryDNA, 23andMe, and National Geographic genetics tests — here's how to choose one to try

$
0
0

Helix DNA 7

  • I tried DNA tests from 23andMe, Ancestry, and National Geographic to learn about my family's history and my health
  • The tests vary in terms of what information they provide and how precise they are
  • Determine which test to try depends on what you hope to learn

 

I've sent my spit off for more genetics tests than anyone else I know.

These tests analyzed my saliva to find out a host of different things that my DNA can tell me about my ancestry and health. 

Genetic testing companies have proprietary sets of data and various ways of analyzing information, so each one I tried offered a distinct approach. One provided details about my great-grand relatives, while others listed how much Neanderthal DNA I have. 

Every so often, someone asks me which test I recommend. And my answer boils down to one question: What do you want to get out of the test? 

Let's compare three direct-to-consumer tests: AncestryDNA, 23andMe, and National Geographic's Geno 2.0 test. 

23andMe gave me a comprehensive picture of my health and ancestry that keeps growing

23andMe kit

23andMe currently offers two versions of its test: The $199 version comes with health and ancestry components, whereas the $99 version just has the ancestry test.

To analyze your DNA, 23andMe uses a technique called genotyping. Humans have 3 billion base pairs of DNA in our genome — that's a lot of information to sift through — so genotyping technology looks for specific parts of DNA and pieces them together.

The health reports can tell you information about your physical traits (like if you're likely to have dimples or curly hair), wellness (how well you metabolize caffeine or if you're a sprinter), and carrier status for certain genetic mutations.

The FDA now allows 23andMe to provide reports on a person's genetic risk for certain diseases, including Alzheimer's and Parkinson's diseases. In total, the test now has more than 74 reports, and more get added all the time. I often get emails telling me that a new test is ready for me — recently I got one that looks at my genetic health risk for celiac disease. 

With 23andMe's ancestry reports, users have access to information about their ancestry composition (which geographic regions your genes align with), haplogroups (genetic populations that share a common ancestor), and Neanderthal ancestry. They also get access to something called a DNA Relatives tool, which 23andMe users can opt into to connect with other users and find out whether they have relatives in the system.

 

Screen Shot 2015 12 17 at 5.54.33 PM

Verdict: If you're looking at this test as a science experiment, using it as a way to get involved in research, or viewing it as a chance to learn about your genetic health risks, then this is a fit for you. (Though if you opt for the full test, there are some considerations patient groups and genetic counselors would like users to take into account.)

If you just want to know your ancestry percentages and how much Neanderthal variants you have, the $99 version is a good bet. But if ancestry is your primarily interest, read on.

AncestryDNA connects the dots between you and your ancestors 

AncestryDNA test box

Ancestry's test, as its name suggests, is all about family histories and genealogy. You won't find health and wellness reports in its $99 test, but you will find information about where your family comes from and how that lineage connects you to potential ancestors.

Like 23andMe, Ancestry uses genotyping technology to analyze your DNA. The service also helps you link up your DNA test to a self-reported family tree. 

There's a lot to discover within that data — for example, I was matched up with ancestors dating back to the 18th century, and could explore how I was connected to them. 

Screen Shot 2016 03 30 at 4.41.49 PM

If you simply want to know, say, what percent Scandinavian you are, Ancestry's site makes it easy to focus on those numbers. Those who want to dig deep into family trees can do that as well. I would definitely consider purchasing this test for a relative who enjoys researching family history.

Ancestry has also added a DNA story element that maps out your ancestors' migration patterns. My ancestors started moving to the Midwest in the US around 1825-1850. 

Screen Shot 2017 11 21 at 11.57.21 AM

Verdict: If the idea of tracing your family tree through the generations and connecting with distant relatives gets you excited — but you're less interested in health information — this is the test for you. 

National Geographic's test uses next-generation sequencing technology to inform its reports

Helix DNA 1National Geographic has an ancestry test called Geno 2.0.

The test — which currently costs $99.95 but originally was $199.95— is different from AncestryDNA and 23andMe in that it uses next-generation sequencing instead of genotyping technology. 

Unlike genotyping, which just looks for specific parts of DNA and pieces them together, next-generation sequencing looks at only the protein-encoding parts of your genome, called the exome. The next-generation sequencing analyzes roughly 2% of those 3 billion base pairs. 

The additional information this technique picks up could lead to new, more specific genetic testing features in the future, especially as our knowledge of the genome and exome continues to grow.

Helix DNA 5

Based on next-generation sequencing, National Geographic's test provides three ancestry reports.

  • Regional, which tells you where your ancestors came from more than 500 years ago. This didn't get into as many specifics in my case as AncestryDNA and 23andMe's tests did. 
  • Deep, which shows your ancestors' migration patterns thousands of years ago.
  • Hominin ancestry, which tells you how much DNA you have in common with a Neanderthal.

The verdict: For what you get, the test doesn't have nearly the range that other ancestry tests have. And when not on sale, it's more expensive. National Geographic, however, says the revenue funds nonprofit "conservation, exploration, research, and education" efforts.

There are other ancestry tests I have yet to try

MyHeritage has a DNA test that's currently going for $49 (originally $99). Its tests, like Ancestry's, are focused on building family connections and trees. 

Others, like FamilyTree DNA (which offers tests from $59) are also geared toward people who want to find genetic links to relatives.

Each company has its own methods, algorithms, and data, which is why the reports differ. Because the three main direct-to-consumer genetics tests are around the same price, you should go with the one that will answer your most pressing questions.

This post was originally published in April 2017 and has been updated. 

SEE ALSO: I shipped my spit to AncestryDNA to see how much I could learn from my genes — and found out my family history is more complex than I thought

DON'T MISS: I revisited my 23andMe DNA test results that can now tell if you're at an increased risk of diseases — here's what it was like

Join the conversation about this story »

NOW WATCH: Scientists found a genetic mutation that makes it healthier for some people to be vegetarian

I tried National Geographic's next-generation ancestry test and was surprised by my results

$
0
0

Helix DNA 6

By now, I should have a crystal-clear picture of my ancestry.

Both 23andMe and AncestryDNA have done a good job of confirming my Scandinavian origins.

So when I decided to try National Geographic's new Geno 2.0 test, I expected my results to be roughly the same.

National Geographic's Genographic Project has been around since 2005, making it one of the earliest genetics tests. A few months ago, it switched over to Helix's next-generation sequencing platform for its Geno 2.0 test.

What I got in my inbox looked nothing like what I'd seen before.

SEE ALSO: 2 tragedies intersected to give this man a face transplant — and the story that unfolded is powerful

DON'T MISS: I've taken AncestryDNA and 23andMe genetics tests — here's what I tell people when they ask me which one is best

A box containing my Genographic Project Geno 2.0 test arrived at my office in December, and I couldn't wait to check it out.



Inside the sleeve was a booklet and a box from Helix. A company spun off from the sequencing giant Illumina, Helix is positioning itself as the app store for your DNA. Once I sent in the tube of spit containing my DNA, Helix could apply that information to other tests down the line — not just the National Geographic one I was trying.

Source: Business Insider



The box was unlike other DNA tests I've tried. The combination of geometric shapes and bright boxes made it fun, and when I lifted up the pink box I found a helpful tip written underneath: "Having trouble salivating? Think about lemons!"



See the rest of the story at Business Insider

You can get a 23andMe genetic test kit for half off this Black Friday

$
0
0

The Insider Picks team writes about stuff we think you'll like. Business Insider has affiliate partnerships, so we get a share of the revenue from your purchase.

23andMe

By nature, Black Friday is a day that's very much so about materialism. Consumers flood stores and online sites in search of deals on tech, clothes, shoes, home goods, and more. But if you want to look passed material things on the outside, and focus on what's inside, 23andMe is the perfect way to do so.

The 23andMe kit is one of the most in-depth at-home DNA tests you can take. Not only will it break down your ancestry, it will also discover your genetic health risks for diseases like Parkinson's or Alzheimer's, carrier traits for diseases like Cystic Fibrosis and Sickle Cell, report on your wellness with details like sleep patterns and lactose intolerance, and other genetic traits.

It's super easy to use, too. Order the kit, spit into the provided tube, mail it back to the lab in the pre-paid packaging, and get your results in 6-8 weeks.

With so much useful information packed inside the results, the regular $199.99 price tag is well worth it, but the deal is even better for Black Friday. Today only, you can get the 23andMe DNA Test Kit for $99.99 (half price) on Amazon.

If you've ever been curious about your genetic makeup or you're looking for an extremely insightful gift for holidays, this is the best time to get one.

Learn more about yourself with a 23andMe DNA kit now.

23andMe Health and Ancestry DNA Test, $99.99 (Originally $199.99)[You save $100]

To check out other great Black Friday deals on Amazon, click here.

Join the conversation about this story »

You might have more control over aging than you think — here are 5 things you can do to slow it down

$
0
0

richard branson young and old

  • Chromosome ends called telomeres prompt the aging process in cells.
  • Nobel Laureate Elizabeth Blackburn says we have more control over our telomeres than we think.
  • In her recent TED talk, she details some of the key ways people can live more healthful lives into old age. 


Aging: it's largely your chromosomes' fault. That’s what biologist Elizabeth Blackburn discovered when she started exploring the world of the invisible, threadlike cellular strands that carry our genetic code. 

She revealed her decades-long process of discovery in a TED talk from April that was posted online this week.

In the talk, Blackburn detailed how the cells dividing and multiplying inside our bodies each carry chromosomes that are bookended by vitally-important caps called telomeres.

You can think of the DNA-strand tips “like the protective caps at the ends of your shoelace,” she said. And just like those shoelace ends, telomeres fray and wear over time. Eventually, telomeres get so short that they fall off. “It’s the overshortening of telomeres that leads us to feel and see signs of aging,” Blackburn said. "It sends a signal. Time to die." 

But it doesn’t have to be that way.

Blackburn shared the 2009 Nobel Prize in medicine with Carol Greider and Jack Szostak for discovering how telomeres, and an enzyme they named telomerase, can protect our chromosomes and make them last longer. Now thousands of studies based on that discovery are starting to shed light on simple ways we can control how short our telomeres get.

Here are a few key things people can do to keep their telomeres long. While these tips won't make you live forever, they  can help with human “health span” — the number of years a person lives happily, and disease-free. 

Manage Stress

The more chronically stressed we are, the shorter our telomeres become. Research conducted by Blackburn that focused on mothers caregiving for children with autism and other chronic conditions revealed that moms who were more resilient to stress — perceiving their situation as a challenge, rather than a stressor — kept their telomeres longer.

“Attitude matters,” Blackburn says.“If you typically see something stressful as a challenge to be tackled, then blood flows to your heart and to your brain, and you experience a brief but energizing spike of cortisol." 

Meditate

In case you haven’t heard enough about how great it can be to add meditation into your routine, here’s another way researchers have found it helps: Family members who meditated for as little as 12 minutes a day for two months while caring for a relative with dementia improved their telomere maintenance

Invest in your neighborhood

“Emotional neglect, exposure to violence, bullying and racism all impact your telomeres, and the effects are long-term,” Blackburn said. Meanwhile, tight-knit communities can be good for telomere health.

Get married and maintain lifelong friendships 

In a 2013 study of 298 adults ages 65-74, participants who were married were found to have longer telomeres. Long term friendships can also help telomere health, according to Blackburn. 

Make lots of money

Money can't buy love, but apparently, it might buy some longer chromosomes. The same study that pointed to the benefits of marriage also reported that high income is associated with longer telomeres. 

Watch Blackburn reveal her entire journey from pond scum explorer to Nobel Laureate here: 

 

SEE ALSO: I tested my dog's DNA and learned she's not even close to the breed I thought

Join the conversation about this story »

NOW WATCH: Scientists discovered people who are highly-intelligent have 52 genes in common

Viewing all 463 articles
Browse latest View live


<script src="https://jsc.adskeeper.com/r/s/rssing.com.1596347.js" async> </script>